Abstract:While most individuals suffer progressive disease following HIV infection, a small fraction spontaneously controls the infection. Although CD8 T-cells have been implicated in this natural control, their mechanistic roles are yet to be established. Here, we combined mathematical modeling and analysis of previously published data from 16 SIV-infected macaques, of which 12 were natural controllers, to elucidate the role of CD8 T-cells in natural control. For each macaque, we considered, in addition to the canonical in vivo plasma viral load and SIV DNA data, longitudinal ex vivo measurements of the virus suppressive capacity of CD8 T-cells. Available mathematical models do not allow analysis of such combined in vivo - ex vivo datasets. We explicitly modeled the ex vivo assay, derived analytical approximations that link the ex vivo measurements with the in vivo effector function of CD8-T cells, and integrated them with an in vivo model of virus dynamics, thus developing a new learning framework that enabled the analysis. Our model fit the data well and estimated the recruitment rate and/or maximal killing rate of CD8 T-cells to be up to 2-fold higher in controllers than non-controllers (p = 0.013). Importantly, the cumulative suppressive capacity of CD8 T-cells over the first 4–6 weeks of infection was associated with virus control (Spearman's ρ = -0.51; p = 0.05). Thus, our analysis identified the early cumulative suppressive capacity of CD8 T-cells as a predictor of natural control. Furthermore, simulating a large virtual population, our model quantified the minimum capacity of this early CD8 T-cell response necessary for long-term control. Our study presents new, quantitative insights into the role of CD8 T-cells in the natural control of HIV infection and has implications for remission strategies. HIV infection results in progressive disease culminating in AIDS in most individuals if left untreated. A rare set of individuals, called natural controllers, however, can control the virus without treatment. Understanding what underlies such control may help devise strategies to elicit it in non-controllers. A challenge has been the limited understanding of the mechanistic role of CD8 T-cells. Here, using new mathematical modeling which enabled simultaneous analysis of in vivo and ex vivo longitudinal data from macaques infected with SIV, we identified the cumulative infection suppressive capacity of CD8 T-cells early in infection (4–6 weeks) as a measurable correlate of control in the chronic phase of the infection. This cumulative suppressive capacity was significantly higher in controllers than non-controllers, attributed by our model to superior CD8 T-cell recruitment rate and/or maximal killing rate in the controllers. Our study quantifies the role of CD8 T-cells in the natural control of SIV and has implications for interventions targeting long-term HIV remission.

Early Env-specific CTLs Effectively Suppress Viral Replication in SHIV Controller Macaques

CTL-mediated Immunotherapy Can Suppress SHIV Rebound in ART-free Macaques.

Investigations on four host response factors whose expression is enhanced in X4 SHIV encephalitis.

The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.

The Effect of Early Versus Delayed Challenge after Vaccination in Controlling SHIV 89.6P Infection

Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data

Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection

Gag-specific Cellular Immunity Determines in Vitro Viral Inhibition and in Vivo Virologic Control Following SIV Challenges of Vaccinated Monkeys

The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

Title Acute infection of chinese macaques by a CCR 5-tropic SHIVcarrying a primary HIV-1 subtype B ' envelope

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection

Envelope Residue 375 Substitutions in Simian–human Immunodeficiency Viruses Enhance CD4 Binding and Replication in Rhesus Macaques

Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused simian immunodeficiency virus controllers

Suppression of HIV Replication by CD8+ Regulatory T-Cells in Elite Controllers

Early antibody therapy can induce long-lasting immunity to SHIV

CD4+ T cell depletion does not affect the level of viremia in chronically SHIVSF162P3N-infected Chinese cynomolgus monkeys

Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapy

Rapid Development of Gp120-Focused Neutralizing B Cell Responses During Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.

Acute Infection of Chinese Macaques by a CCR5-tropic SHIV Carrying a Primary HIV-1 Subtype B' Envelope.

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells